| EX1037 HYPERTHYROID / GRAVES’ DISEASE PANEL |
| Specimen: |
4 mL ( 3 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| 2 hrs |
72 hrs |
4 weeks |
|
| Method: |
CLIA, ECLIA |
| Comment: |
|
| Report: |
Contact us to know the TAT. |
| Usage: |
Graves’ disease accounts for 60-80% of Thyrotoxicosis. The prevalence varies amongst populations reflecting genetic factors and iodine intake. Graves’ disease occurs in up to 2% of women but is 1/10th as frequent in men occurring between 20-50 years of age. The hyperthyroidism of Graves’ disease is caused by Thyroid receptor antibodies which help to monitor the disease. These antibodies in pregnant Graves’ disease patients can cross the placental barrier and lead to Neonatal Thyrotoxicosis. |
| Doctor Specialty: |
Endocrinologist, Physician |
| Disease: |
Disorders of Thyroid |
| Components: |
*Free T4 *TSH *Total T3 *TSH Receptor Antibody |
| Courier Charges: |
0.00 |
| Home Collection: |
Available (*T&C Apply) |
| Department: |
Biochemistry |
| Pre Test Information: |
No special preparation required |
Reviews
There are no reviews yet.